Dec 3 (Reuters) - Regeneus Ltd (RGS) : CHINESE PATENT GRANTED FOR BIOMARKERS TO MONITOR DISEASE PROGRESSION FOR STEM CELL THERAPY Source text :(http://bit.ly/2U6Acnd) (([email protected];))
Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
